ESH 2017 | Infrastructure for AML treatment in Spain
Jorge Sierra
• 5 Oct 2017
Acute myeloid leukemia (AML) is a complex disease with many subtypes; treatment can be more effective and efficient if there is a system in place for centers to cooperate and network to share data and resources. In this interview, Jorge Sierra, MD, PhD, of the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, gives an overview of the current AML treatment center network in Spain, and the resources that the country has access to in order to treat their patients. This interview was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Hematology (ESH).
